189 (Clopidogrel Fig 3)
Clopidogrel Tablet
Product Images NDC 50090-6567
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 50090-6567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Clopidogrel Figure 01)
Figure-2 (Clopidogrel Figure 02)
Figure-4 (Clopidogrel Figure 04)
This text provides information about a study comparing the efficacy of a placebo and the drug Clopidogrel. The study recorded the number of deaths in both groups and found that the Clopidogrel group had slightly lower mortality rates (7.5% compared to 8.1%). The text also mentions a 7% reduction in proportional risk with Clopidogrel, with a p-value of 0.03. The study lasted up to 28 days, and all patients in both groups were treated with aspirin.*
146 (Clopidogrel Figure 05)
Fig-7 (Clopidogrel Figure 07)
Figure-3 (Clopidogrel Figure 3)
Figure-6 (Clopidogrel Figure 6)
Figure-8 (Clopidogrel Figure 8)
Structure (Clopidogrel Structure)
Label Image (Lbl500906567)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
